MET and hepatocellular carcinoma: Inhibition of c-Met activity suppressed the malignant behavior of heat-treated HCC, suggesting that the c-Met/MAPK pathway facilitates the malignant progression of residual HCC cells after IRFA (Jia G. et al., 2020).